Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 1;45(5):305-309.
doi: 10.2500/aap.2024.45.240050.

Immunodeficiency: Complement disorders

Affiliations
Review

Immunodeficiency: Complement disorders

Jeremy C McMurray et al. Allergy Asthma Proc. .

Abstract

The complement system is an important component of innate and adaptive immunity that consists of three activation pathways. The classic complement pathway plays a role in humoral immunity, whereas the alternative and lectin pathways augment the innate response. Impairment, deficiency, or overactivation of any of the known 50 complement proteins may lead to increased susceptibility to infection with encapsulated organisms, autoimmunity, hereditary angioedema, or thrombosis, depending on the affected protein. Classic pathway defects result from deficiencies of complement proteins C1q, C1r, C1s, C2, and C4, and typically manifest with features of systemic lupus erythematosus and infections with encapsulated organisms. Alternative pathway defects due to deficiencies of factor B, factor D, and properdin may present with increased susceptibility to Neisseria infections. Lectin pathway defects, including Mannose-binding protein-associated serine protease 2 (MASP2) and ficolin 3, may be asymptomatic or lead to pyogenic infections and autoimmunity. Complement protein C3 is common to all pathways, deficiency of which predisposes patients to severe frequent infections and glomerulonephritis. Deficiencies in factor H and factor I, which regulate the alternative pathway, may lead to hemolytic uremic syndrome. Disseminated Neisseria infections result from terminal pathway defects (i.e., C5, C6, C7, C8, and C9). Diagnosis of complement deficiencies involves screening with functional assays (i.e., total complement activity [CH50], alternative complement pathway activity [AH50], enzyme-linked immunosorbent assay [ELISA]) followed by measurement of individual complement factors by immunoassay. Management of complement deficiencies requires a comprehensive and individualized approach with special attention to vaccination against encapsulated bacteria, consideration of prophylactic antibiotics, treatment of comorbid autoimmunity, and close surveillance.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare pertaining to this article

Figures

Figure 1.
Figure 1.
Overview of the complement system. The central events of the three complement pathways, classic pathway (CP), alternative pathway (AP), and lectin pathway (LP), can be summarized by four important steps: (1) initiation of complement activation, (2) formation of C3 convertase, (3) formation of C5 convertase, and (4) late steps (i.e., terminal pathway).

References

    1. Mayilyan KR. Complement genetics, deficiencies, and disease associations. Protein Cell. 2012; 3:487–496. - PMC - PubMed
    1. Dunkelberger JR, Song W-C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010; 20:34–50. - PubMed
    1. Wen L, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol. 2004; 113:585–593; quiz 594. - PubMed
    1. Prohaszka Z, Nilsson B, Frazer-Abel A, et al. . Complement analysis 2016: clinical indications, laboratory diagnostics and quality control. Immunobiology. 2016; 221:1247–1258. - PubMed
    1. Pettigrew HD, Teuber SS, Gershwin ME. Clinical significance of complement deficiencies. Ann NY Acad Sci. 2009; 1173:108–123. - PubMed

MeSH terms

Substances

LinkOut - more resources